Skip to main content
Equibles
IMCR logo

IMCR · Immunocore Holdings plc · Metrics

Track IMCR — free

Use IMCR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IMCR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$31.44 +1.60 (+5.36%)
Rebalance outlook locked
Market Cap
$1.54B
Shares
51.50M
Volume · Oct 20 77.22K Avg daily vol (3M) 428.7K

IMCR metrics

76 of 116 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$29.84
Market cap
$1.54B

Price action

20 metrics
Price change (1W)
+2.8%
Price change (30D)
-7.3%
Price change (3M)
-12.4%
Price change (6M)
-5.1%
Price change (YTD)
-14.0%
Price change (1Y)
-11.1%
Trailing year
Price change (5Y)
-21.5%
52-week high
$40.22
52-week low
$27.79
Change from 52-week high
-25.8%
Change from 52-week low
+7.4%
Annualized volatility
36.0%
Annualized volatility (3M)
30.0%
Beta
0.6
RSI (14D)
43.6
Price vs SMA 50
-9.5%
Price vs SMA 200
-6.2%
Avg volume (3M)
428,701
Relative volume
0.8
Average dollar volume
$14.13M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
51.50M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.5×
reciprocal yield 28.5%
P / book
3.6
reciprocal yield 27.7%
FCF yield
-2.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-1.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
4.9×
reciprocal yield 20.4%
EV / revenue historical average (5Y)
4.9×
reciprocal yield 20.4%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
98.9%
Operating margin
-5.2%
Trailing 12 months
Net margin
-4.2%
Gross profit (TTM)
$426.04M
Operating profit (TTM)
−$22.58M
Net income (TTM)
−$18.07M
Trailing 12 months
Diluted EPS (TTM)
$-0.38
FCF margin
-9.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$8.49
Gross profit per diluted share (TTM)
$8.39
Operating profit per diluted share (TTM)
$-0.47
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-0.39
Operating cash flow per diluted share (TTM)
$-0.71
Free cash flow per diluted share (TTM)
$-0.83
Capital expenditures per diluted share (TTM)
$0.12
R&D per diluted share (TTM)
$5.62
Stock compensation per diluted share (TTM)
$0.67
Book value per share
$7.52

Growth

11 metrics
Revenue growth YoY
+18.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$430.77M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1.4%
Year over year · more shares
Revenue CAGR (3Y)
+31.9%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-4.3%
Return on assets
-1.6%
Debt / equity
—
Current ratio
4.5
EBITDA (TTM)
—
Free cash flow (TTM)
−$41.15M
Quick ratio
4.4
Interest coverage
-1.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$484.92M
Total assets
$1.12B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$34.96M
Capital expenditures (TTM)
$6.20M
R&D (TTM)
$284.45M
SG&A (TTM)
$164.16M
Stock compensation (TTM)
$33.88M
R&D / revenue
66.0%
Stock compensation / revenue
7.9%

Ownership (13F)

3 metrics
13F filers
135
13F filer change QoQ
-9
Institutional ownership
102.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
1.1%

Short interest

3 metrics
Short interest
15.3%
Latest settlement · 20.7 days to cover
Days to cover
20.7d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1671927 CUSIP 45258D105 13F (30d) 7 filings 7 filers Visit website Investor relations